Strumento inattivo

Altre lingue Yew Bio-Pharm Group, Inc.

Azioni

YEWB

US98584C1018

Altre lingue

Sblocca tutte le notizie: sii il primo a essere informato e reagisci prima dei mercati!

YEW BIO-PHARM GROUP, INC. : Change in Directors or Principal Officers (form 8-K)	29/03/22
Yew Bio-Pharm Group, Inc. Announces Yongchun Shi and Mr. Xiefeng Liu Resigned as the Independent Director	29/03/22
YEW BIO-PHARM GROUP, INC. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS (form 10-Q)	15/11/21
Yew Bio-Pharm Group, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2021	15/11/21
YEW BIO PHARM : MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS (form 10-Q)	16/08/21
Yew Bio-Pharm Group, Inc. Announces Earnings Results for the Second Quarter Ended June 30, 2021	16/08/21
YEW BIO-PHARM GROUP, INC. : Change in Directors or Principal Officers (form 8-K)	27/07/21
Yew Bio-Pharm Group, Inc. Announces Executive Changes	27/07/21
Yew Bio-Pharm Group, Inc. Announces Executive Changes	27/07/21
Yew Bio-Pharm Group, Inc. Announces Executive Changes	27/07/21
YEW BIO PHARM : MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS (form 10-Q)	17/05/21
Yew Bio-Pharm Group, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2021	17/05/21
YEW BIO P : PHARM GROUP, INC. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS (form 10-K)	30/03/21
Yew Bio-Pharm Group, Inc. Reports Earnings Results for the Full Year Ended December 31, 2020	30/03/21
Yew Bio Pharm : Announces New Cosmetic Subsidiary	09/03/21
Yew Bio-Pharm Group, Inc. Announces New Cosmetic Subsidiary	09/03/21
YEW BIO-PHARM GROUP, INC. : Change in Directors or Principal Officers (form 8-K)	05/01/21
Yew Bio-Pharm Group, Inc. Announces Resignation of Guoshuang Tian as Director	05/01/21
Yew Bio-Pharm Group, Inc. Reports Earnings Results for the Third Quarter Ended September 30, 2020	13/11/20
YEW BIO PHARM : MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS (form 10-Q)	13/11/20

Non ci sono risultati per questa ricerca

Tutte le notizie Raccomandazione analisti Eventi più importanti Insiders Resoconti Comunicati stampa Pubblicazioni ufficiali Altre lingue Idee di trading Articoli MarketScreener Analisi MarketScreener

Altre lingue Yew Bio-Pharm Group, Inc.

Azioni

YEWB

US98584C1018

Altre lingue

Filtri